Nuvation Bio Inc (NUVB) requires closer examination

Patricia Turner

While Nuvation Bio Inc has underperformed by -2.92%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, NUVB rose by 37.59%, with highs and lows ranging from $4.09 to $1.54, whereas the simple moving average jumped by 51.55% in the last 200 days.

On September 30, 2025, Jefferies started tracking Nuvation Bio Inc (NYSE: NUVB) recommending Buy. A report published by Citizens JMP on April 23, 2025, Initiated its previous ‘Mkt Outperform’ rating for NUVB. Jefferies also Upgraded NUVB shares as ‘Buy’, setting a target price of $10 on the company’s shares in a report dated March 27, 2024. Jefferies January 06, 2023d its ‘Buy’ rating to ‘Hold’ for NUVB, as published in its report on January 06, 2023. BMO Capital Markets also rated the stock as ‘Market Perform’.

Analysis of Nuvation Bio Inc (NUVB)

Further, the quarter-over-quarter increase in sales is 236.79%, showing a positive trend in the upcoming months.

Nuvation Bio Inc’s future performance can be predicted by a variety of well-rounded types of analysis and research, with equity being one of the most crucial ones. The goal here is to ensure that your current return on equity of -64.40% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 9.38, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

For any stock, average volume can be an extremely valuable indicator of volatility, and NUVB is registering an average volume of 5.98M. On a monthly basis, the volatility of the stock is set at 7.24%, whereas on a weekly basis, it is put at 6.46%, with a loss of -1.08% over the past seven days. Furthermore, long-term investors anticipate a median target price of $8.71, showing growth from the present price of $3.66, which can serve as yet another indication of whether NUVB is worth investing in or should be passed over.

How Do You Analyze Nuvation Bio Inc Shares?

Besides checking the fundamentals, you should also know how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 32.56%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 53.53% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.